What does loans and leases receivable related parties mean?

This reflects the outstanding principal balance of loans or lease agreements extended to affiliated entities or related parties. These transactions are often subject to specific governance and oversight due to the potential for conflicts of interest. Monitoring this helps investors assess the company's capital deployment to related entities and potential credit exposure.

King Pharmaceuticals KG Loans And Leases Receivable Related Parties

Loans And Leases Receivable Related Parties at other companies

Kearny FinancialKRNY

$2.3M-4.2%

Community Financial SystemCBU

$14.17M+34.5%

Segments

By segment

See full

Legacy Reinsurance$78.61M—

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LoansAndLeasesReceivableRelatedParties.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's loans and leases receivable related parties.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's loans and leases receivable related parties?: King Pharmaceuticals (KG) reported loans and leases receivable related parties of $78.61M in Q1 2026.
What does loans and leases receivable related parties mean?: This reflects the outstanding principal balance of loans or lease agreements extended to affiliated entities or related parties. These transactions are often subject to specific governance and oversight due to the potential for conflicts of interest. Monitoring this helps investors assess the company's capital deployment to related entities and potential credit exposure.